Bumper Offer - Urjas oil Just @ Rs. 1
Uribact, a prescription drug, is manufactured in various forms such as Tablet. Urinary Tract Infection, Prostatitis, Pneumonia are some of its major therapeutic uses. Other than this, Uribact has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Uribact is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Uribact have been listed ahead. Usually, these side effects of Uribact go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Uribact's effect is Moderate during pregnancy and Severe for lactating mothers. Warnings related to Uribact's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Coronary Artery Disease (CAD), Heart Disease, Myasthenia Gravis (MG) must refrain from the use of Uribact since this can cause severe adverse effects. Other conditions have been mentioned below in the Uribact contraindications section.
Additionally, Uribact may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Uribact is not safe while driving, and is is not addictive in nature.
Uribact is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Uribact is used -
Severe
Moderate
Mild
Is the use of Uribact safe for pregnant women?
Uribact may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Uribact again without your doctor's advice.
Is the use of Uribact safe during breastfeeding?
Uribact should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Uribact on the Kidneys?
Uribact rarely harms the kidneys.
What is the effect of Uribact on the Liver?
Uribact does not damage the liver.
What is the effect of Uribact on the Heart?
There are no any side effects of Uribact for the heart.
Uribact should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Uribact unless your doctor advises you to do so -
Is this Uribact habit forming or addictive?
No, you will not get addicted to Uribact.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Uribact can make you feel drowsy.
Is it safe?
Yes, but consume Uribact only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Uribact in mental disorders is not effective.
Interaction between Food and Uribact
When consumed with certain foods, Uribact may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Uribact
Side effects of drinking alcohol and taking Uribact at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
